Liposomal Urolithin A: Is It Better?
Liposomal delivery is one of the most heavily marketed words in the supplement aisle, and it now appears on some urolithin A products too. This guide explains what liposomal actually means, what the absorption claims rest on, and why the single most important thing is still whether a product delivers a clinically studied dose.
What 'liposomal' actually means
A liposome is a microscopic sphere built from phospholipids, the same class of fat molecules that make up your own cell membranes. Because a phospholipid has a water-loving head and a water-avoiding tail, these molecules naturally arrange themselves into a bilayer shell when mixed in water. Manufacturers use that shell to wrap an active ingredient, the idea being that the fatty envelope helps the payload survive the stomach and cross the gut lining more efficiently than a raw powder would.
The concept is genuinely rooted in pharmaceutical science. Liposomes have been used for decades to deliver certain injectable drugs where controlling where and how fast a compound is released matters a great deal. The open question for the supplement shelf is whether that same engineering, in an oral capsule or liquid, produces a meaningful difference for the specific molecule inside, in real people, at the dose on the label. That is a much narrower and more demanding question than 'do liposomes work in general'.
Why absorption matters for urolithin A specifically
Urolithin A is a gut postbiotic. Your body does not typically get it directly from food. Instead, your microbiome converts ellagitannins from pomegranate, walnuts and certain berries into urolithin A. The catch, and the reason direct supplementation became interesting at all, is that only some people carry the gut bacteria needed to make useful amounts. Estimates from the research literature suggest a large share of adults are poor converters, which is why taking the finished molecule can make sense.
Because urolithin A is fat-associated and not highly water-soluble, absorption is a legitimate scientific consideration, and it is the reason delivery formats get discussed at all. This is where it helps to separate what has been tested from what is being assumed. To learn more about the compound itself, our urolithin A guide and our overview of the clinical studies lay out the foundations.
What the human evidence was actually built on
Here is the point that gets lost in liposomal marketing. The human trials that made urolithin A credible did not use a liposomal format. They used a well-characterized, purified form of urolithin A.
Proven in humans (foundational safety and mechanism). Andreux and colleagues (2019, Nature Metabolism) ran the first-in-human study. Urolithin A was safe and well tolerated at doses up to 1,000 mg per day, and it produced a favorable mitochondrial gene-expression signature in older adults. This is the study that established a workable, studied dose range.
Proven in humans (muscle and performance). Liu, D'Amico and colleagues (2022, JAMA Network Open) reported that roughly four months of supplementation supported muscle endurance, measured as the number of muscle contractions before fatigue, in older adults. Singh and colleagues (2022, Cell Reports Medicine) tested 500 mg and 1,000 mg arms in middle-aged adults over four months and reported support for muscle strength and exercise performance.
Newer human research. A 2025 Nature Aging randomized trial (about 28 days) reported support for immune-cell mitochondrial health in midlife adults, a theme sometimes discussed under inflammaging. A 2024 randomized trial in the Journal of the International Society of Sports Nutrition looked at endurance and recovery markers in resistance-trained men over eight weeks, and a 2025 trial in distance runners added further data in trained athletes.
The honest ceiling. A 2024 systematic review in Ageing Research Reviews, focused on targeting aging with urolithin A in humans, concluded that the evidence is still emerging, drawn from relatively short trials of modest size. That is the correct frame for the whole category, liposomal or not.
Preclinical foundations (animal and cell, not human proof). The mechanism traces back to Ryu and colleagues (2016, Nature Medicine), who showed urolithin A triggers mitophagy, the recycling of worn-out mitochondria, and extended lifespan in the worm C. elegans while improving muscle function in rodents. These are foundational but preclinical results.
So is liposomal urolithin A worth paying more for?
The most honest answer is that it depends on evidence that, for this specific molecule in this specific format, is thin. A few principles help you reason about it rather than react to it.
1. Delivery format is a means, not the goal
The goal is to get a studied amount of urolithin A into your system consistently. If a liposomal product delivers a smaller dose, or a dose the brand will not clearly state, then whatever theoretical absorption edge it claims can be undone by simply having less active ingredient to begin with. Always read the actual milligrams of urolithin A per serving, not just the marketing on the label.
2. 'Better absorbed' should be shown, not asserted
A credible absorption claim is backed by a published pharmacokinetic comparison in humans, ideally head-to-head against the standard form. Broad statements that liposomes are 'up to' some multiple more bioavailable often generalize from other nutrients entirely, or from lab conditions, not from a trial of that finished product. When you see a number, ask what molecule, what comparison and what population produced it.
3. Adherence quietly wins
Every human urolithin A trial ran for weeks to months. The format you will genuinely take every day, without fuss, is the one that gives the science a chance to matter. For many people a pleasant gummy clears that bar more reliably than a large oil-based capsule or a liquid that needs refrigeration. We compare formats in more depth in our roundup of the best urolithin A gummies.
4. Watch dose, testing and transparency first
Before you weigh delivery systems, confirm the fundamentals: a clearly stated dose in the 500 to 1,000 mg range, third-party testing, and a brand that does not overpromise. Our page on urolithin A dosage walks through why that range is the reference point.
How SOMA HEALTH approaches this
SOMA HEALTH chose to compete on the fundamentals rather than on a delivery buzzword. Each 4-gummy daily serving provides 1,000 mg of urolithin A, the top of the clinically studied range, in a sugar-free raspberry gummy that is third-party tested. The reasoning is straightforward: put a studied dose into a format people enjoy taking daily, and be transparent about what the evidence does and does not yet show. Urolithin A is not a treatment for any disease, and it is not a substitute for medical care. It is a way to support mitophagy and mitochondrial health as part of a broader routine.
Frequently asked questions
Is liposomal urolithin A clinically proven to work better?
Not to a standard that would let anyone say so confidently. The published human trials that established urolithin A's safety and effects used a purified, non-liposomal form. Claims that a liposomal version absorbs better should be backed by a human pharmacokinetic comparison of that actual product, which is rarely provided.
What does liposomal mean in plain terms?
It means the active ingredient is wrapped in a shell made of phospholipids, the same fat molecules found in your cell membranes. The theory is that this fatty envelope helps the payload survive digestion and cross the gut lining. It is a real pharmaceutical concept, but its benefit depends on the specific molecule, dose and formulation.
Why do people supplement urolithin A instead of just eating pomegranate?
Urolithin A is made by gut bacteria from compounds in pomegranate, walnuts and berries, but only some people carry the microbes needed to produce useful amounts. Supplementing the finished molecule bypasses that lottery. Our foods guide covers the dietary side.
What dose of urolithin A was studied?
The clinically studied range is 500 to 1,000 mg per day, with 1,000 mg at the top of that range. SOMA HEALTH gummies deliver 1,000 mg in a 4-gummy daily serving.
Does a gummy absorb urolithin A well enough?
What matters most is delivering a studied dose consistently over weeks to months, which is how every human trial was run. A pleasant gummy that you take daily gives the science a fair chance. See our how to take it guide for timing tips.
Is urolithin A safe?
In the first-in-human study, urolithin A was safe and well tolerated at doses up to 1,000 mg per day. As with any supplement, if you are pregnant, nursing, taking medication or managing a health condition, this is not a treatment, so talk with your doctor before starting.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →